Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-19-004990
Filing Date
2019-04-08
Accepted
2019-04-05 21:40:17
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 1011389
2 ex23-1.htm EX-23.1 4925
3 ex31-1.htm EX-31.1 11678
4 ex31-2.htm EX-31.2 11958
5 ex32-1.htm EX-32.1 7801
  Complete submission text file 0001493152-19-004990.txt   4134861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pcsa-20181231.xml EX-101.INS 478832
7 XBRL SCHEMA FILE pcsa-20181231.xsd EX-101.SCH 49863
8 XBRL CALCULATION FILE pcsa-20181231_cal.xml EX-101.CAL 62739
9 XBRL DEFINITION FILE pcsa-20181231_def.xml EX-101.DEF 191573
10 XBRL LABEL FILE pcsa-20181231_lab.xml EX-101.LAB 371369
11 XBRL PRESENTATION FILE pcsa-20181231_pre.xml EX-101.PRE 295898
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-184948 | Film No.: 19736275
SIC: 2834 Pharmaceutical Preparations